ST Pharm Co.,Ltd. (KOSDAQ:237690)
South Korea flag South Korea · Delayed Price · Currency is KRW
143,300
+2,200 (1.56%)
Apr 10, 2026, 3:30 PM KST

ST Pharm Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
2,938,8452,467,6411,790,0291,275,2351,647,6492,596,915
Market Cap Growth
92.89%37.85%40.37%-22.60%-36.55%34.10%
Enterprise Value
2,926,1302,427,6161,811,0531,375,6951,714,0242,628,966
Last Close Price
141100.00118825.8688620.9767198.7686117.30136081.99
PE Ratio
52.4944.8751.5765.1391.54784.06
Forward PE
46.2639.8836.2237.6967.19133.19
PS Ratio
8.867.446.544.476.6115.68
PB Ratio
4.964.163.563.304.837.97
P/TBV Ratio
5.104.283.683.445.078.37
P/FCF Ratio
--67.18---
P/OCF Ratio
210.08176.4016.36982.17234.34357.22
EV/Sales Ratio
8.827.326.624.836.8815.87
EV/EBITDA Ratio
34.5028.6233.9924.3348.35131.50
EV/EBIT Ratio
53.2744.1965.4041.0596.02471.35
EV/FCF Ratio
-88.45-67.97---
Debt / Equity Ratio
0.130.130.240.500.390.33
Debt / EBITDA Ratio
0.930.932.223.403.795.38
Debt / FCF Ratio
--4.43---
Net Debt / Equity Ratio
-0.02-0.02-0.010.260.250.04
Net Debt / EBITDA Ratio
-0.14-0.14-0.051.802.380.72
Net Debt / FCF Ratio
0.370.37-0.10-2.43-1.58-0.32
Asset Turnover
0.440.440.390.460.470.35
Inventory Turnover
1.341.341.461.541.721.75
Quick Ratio
1.151.151.432.530.823.00
Current Ratio
2.262.262.484.161.474.64
Return on Equity (ROE)
9.96%9.96%7.30%4.81%5.25%1.08%
Return on Assets (ROA)
4.56%4.56%2.48%3.36%2.09%0.74%
Return on Invested Capital (ROIC)
9.30%9.44%4.25%5.50%4.25%1.79%
Return on Capital Employed (ROCE)
8.90%8.90%4.70%5.70%4.60%1.30%
Earnings Yield
1.87%2.23%1.94%1.54%1.09%0.13%
FCF Yield
-1.13%-1.34%1.49%-3.29%-3.24%-1.71%
Payout Ratio
18.32%18.32%27.09%48.03%52.25%-
Buyback Yield / Dilution
-9.95%-9.95%-3.70%--0.77%-0.05%
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.